A PYMNTS Company

US: Cigna shareholders approve Express Scripts deal

By  |  August 26, 2018

Health insurer Cigna said its shareholders Friday morning approved the company’s proposed $67 billion purchase of pharmacy benefits manager Express Scripts.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    During a special meeting Friday, about 90% of shareholders approved the merger agreement despite recent pushback from activist shareholder Carl Icahn and Sen. Chuck Grassley from Iowa, the top Republican on the Senate Judiciary Committee.

    “Our combined company will enhance Cigna’s differentiated service-based model, fueled by actionable insights and analytics, to drive innovation and meaningful growth in a highly dynamic market environment,” Cigna CEO David Cordani said in a statement. “As a result, we will build more effective partnerships, further improve health outcomes and deliver a superior customer experience.”

    The US Department of Justice is performing an antitrust review of the proposed merger, which is expected to be completed later this year. Cigna said it expects the deal, subject to customary closing conditions and regulatory approvals, to close by year-end 2018.

    Full Content: Forbes

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.